PCF names new directors

The Pharmacy Compounding Foundation has elected five board members read more →
Our state-by-state 795-797-800 chart has been updated

APC has posted an updated version of our compilation of state by state adoption of USP <795>, <797>, and <800>. read more →
Novo alleges potency discrepancy, impurities in compounded semaglutide

We’ll let you read it for yourself. Interesting how the reporter seems to take Novo’s word for it, no? read more →
APC files amicus in Novo case against Tennessee compounder

A U.S. District Court judge approved APC filing an amicus brief this week in Novo Nordisk’s lawsuit against Tennessee compounder (and APC PFM) DCA Pharmacy. read more →
A $100,000 deficit

One of the challenges of being an ambitious but resource-poor association is that we have to spend a lot of time asking members like you for money. read more →
Telling your story, one reporter at a time

The photo inset below on the left was taken last Friday morning at Preston’s Pharmacy (a PFM, I might add) in Arlington, Virginia. It’s not a pharmacist or technician in the photo. It’s a healthcare reporter. read more →
There’s a lot you can learn from errors

Patient safety is job one in any pharmacy, but especially in compounding pharmacies. So on those rare occasions when errors occur — in your pharmacy or someone else’s — you want to be able to learn from them. read more →
What does FD&C Act really say about USP compliance?

In response to inquiries from state boards of pharmacy regarding the enforceability of revised USP Chapters <795>, <797>, and <800>, a recent memo aims to clarify references in the Food, Drug & Cosmetic Act. read more →
Letter seeks clarity on semaglutide compounding in California

Last week, we sent a letter to the California Board of Pharmacy requesting clarification of its position on compounding semaglutide. read more →